Meet DelveInsight in BioEurope '16

  • Home Blog Meet delveinsight in bioeurope 16

Meet DelveInsight in BioEurope '16

Nov 02, 2016

p2-n

Downloads

Article in PDF

Recent Articles
  1. FDA Expands SOLIRIS for Pediatric Myasthenia Gravis; vTv’s Cadisegliatin Program Resumes as FDA L...
  2. Idiopathic pulmonary fibrosis (IPF) – Market Insights, Epidemiology and Market Forecast-2020
  3. Bile Duct Cancer (Cholangiocarcinoma) -Pipeline Insights, 2015
  4. Orphan drug development strategies
  5. Neurotech’s ENCELTO Becomes First FDA-Approved Treatment for MacTel Type 2; Plus Therapeutics’ Rh...
exploring-life-saving-heart-devices-innovations-transforming-cardiac-care
Articles

Exploring Life-Saving Heart Devices: Innovations Transforming Cardiac Care

pharma-news-for-celltrion-csl-ocugen
Notizia - Recent Pharma, Healthcare and Biotech Happenings

Celltrion Announces FDA Nod for New STEQEYMA Presentation to Broaden Pediatric Use; CSL’s ANDEMBRY Gets FDA Nod as First Factor XIIa Inhibitor for Hereditary Angioedema; Ocugen’s OCU410ST Cleared by FDA to Begin Phase II/III Trial in Stargardt Disease; Milestone Pharmaceuticals Submits FDA Response for CARDAMYST in PSVT; AbbVie’s MAVYRET Approved by FDA as First and Only Therapy for Acute Hepatitis C

pharma-news-for-amylyx-cellectar-merck
Notizia - Recent Pharma, Healthcare and Biotech Happenings

Amylyx’s AMX0114 Fast Tracked by FDA for ALS; Cellectar’s Iopofosine I 131 Granted FDA Breakthrough in Waldenstrom Macroglobulinemia; YolTech’s YOLT-101 Clears FDA IND for Familial Hypercholesterolemia; Oncovita’s MVdeltaC Gets FDA Orphan Tag for Pleural Mesothelioma; Merck’s ENFLONSIA Approved for RSV Prevention in Infants

BioEurope
Conference
DelveInsight
loader
loader